Reset Pharmaceuticals

About:

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.

Website: https://www.resetpharma.com

Twitter/X: resetpharma

Top Investors: PsyMed Ventures, Negev Capital, Ayuh Ventures

Description:

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. Its program focuses on psilocybin with psychotherapy for patients with cancer-related demoralization, anxiety, and depression.

Total Funding Amount:

$11.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)resetpharma.com

Founders:

Jan-Anders Karlsson

Number of Employees:

11-50

Last Funding Date:

2022-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai